Literature DB >> 23487331

Carpal tunnel syndrome.

Philippe A Peetrons1, Wafa Derbali.   

Abstract

Ultrasound (US) of the carpal tunnel adds value to the usual electrophysiology diagnosis by confirming doubtful results or evaluating patients who do not improve after surgery. US sometimes provides the surgeon or the referring physician with important information about normal variants or common or even rare causes of the nerve compression. The size of the median nerve must be calculated in the short axis by measuring the nerve cross-sectional area where the nerve is the thickest, in most cases at the proximal entrance of the carpal tunnel. Because the threshold of the nerve size varies in the literature, it is best to consider the cross-sectional median nerve area <8 mm(2) to rule out and ≥12 mm(2) to rule in the diagnosis of carpal tunnel syndrome. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23487331     DOI: 10.1055/s-0033-1333911

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  3 in total

1.  Diagnostic criteria of carpal tunnel syndrome using high-resolution ultrasonography: correlation with nerve conduction studies.

Authors:  Chin Chin Ooi; Siew Kune Wong; Agnes B H Tan; Andrew Y H Chin; Rafidah Abu Bakar; Shy Yunn Goh; P Chandra Mohan; Robert T J Yap; Meng Ai Png
Journal:  Skeletal Radiol       Date:  2014-06-12       Impact factor: 2.199

Review 2.  Sonographic evaluation of peripheral nerve pathology in the emergency setting.

Authors:  Shane Mallon; Vladimir Starcevic; Matthew Rheinboldt; Andrew Petraszko
Journal:  Emerg Radiol       Date:  2018-05-07

3.  The efficiency of acoustic radiation force impulse (ARFI) elastography in the diagnosis and staging of carpal tunnel syndrome.

Authors:  Harun Arslan; Alpaslan Yavuz; Ferda İlgen; Abdurrahman Aycan; Mesut Ozgokce; Hüseyin Akdeniz; Abdussamet Batur
Journal:  J Med Ultrason (2001)       Date:  2018-01-12       Impact factor: 1.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.